The potential role of synovial cells in the progression and treatment of osteoarthritis
Zaijun Zou,
Han Li,
Kai Yu,
Ke Ma,
Qiguang Wang,
Junnan Tang,
Guozhen Liu,
Khoon Lim,
Gary Hooper,
Tim Woodfield,
Xiaolin Cui,
Weiguo Zhang,
Kang Tian
Affiliations
Zaijun Zou
Department of Sports Medicine The First Affiliated Hospital of Dalian Medical University DalianLiaoningChina
Han Li
Department of Sports Medicine The First Affiliated Hospital of Dalian Medical University DalianLiaoningChina
Kai Yu
Department of Bone and Joint Central Hospital of Zhuang He City DalianLiaoningChina
Ke Ma
Department of Clinical Medicine China Medical University ShenyangLiaoningChina
Qiguang Wang
National Engineering Research Center for Biomaterials Sichuan University ChengduSichuanChina
Junnan Tang
Department of Cardiology The First Affiliated Hospital of Zhengzhou University ZhengzhouHenanChina
Guozhen Liu
School of Medicine The Chinese University of Hong Kong (Shenzhen) ShenzhenGuangdongChina
Khoon Lim
Christchurch Regenerative Medicine and Tissue Engineering Group (CReaTE) Department of Orthopaedic Surgery and Musculoskeletal Medicine University of Otago ChristchurchNew Zealand
Gary Hooper
Christchurch Regenerative Medicine and Tissue Engineering Group (CReaTE) Department of Orthopaedic Surgery and Musculoskeletal Medicine University of Otago ChristchurchNew Zealand
Tim Woodfield
Christchurch Regenerative Medicine and Tissue Engineering Group (CReaTE) Department of Orthopaedic Surgery and Musculoskeletal Medicine University of Otago ChristchurchNew Zealand
Xiaolin Cui
Department of Sports Medicine The First Affiliated Hospital of Dalian Medical University DalianLiaoningChina
Weiguo Zhang
Department of Sports Medicine The First Affiliated Hospital of Dalian Medical University DalianLiaoningChina
Kang Tian
Department of Sports Medicine The First Affiliated Hospital of Dalian Medical University DalianLiaoningChina
Abstract Osteoarthritis (OA), the commonest arthritis, is characterized by the progressive destruction of cartilage, leading to disability. The Current early clinical treatment strategy for OA often centers on anti‐inflammatory or analgesia medication, weight loss, improved muscular function and articular cartilage repair. Although these treatments can relieve symptoms, OA tends to be progressive, and most patients require arthroplasty at the terminal stages of OA. Recent studies have shown a close correlation between joint pain, inflammation, cartilage destruction and synovial cells. Consequently, understanding the potential mechanisms associated with the action of synovial cells in OA could be beneficial for the clinical management of OA. Therefore, this review comprehensively describes the biological functions of synovial cells, the synovium, together with the pathological changes of synovial cells in OA, and the interaction between the cartilage and synovium, which is lacking in the present literature. Additionally, therapeutic approaches based on synovial cells for OA treatment are further discussed from a clinical perspective, highlighting a new direction in the treatment of OA.